CelLBxHealth PLC (AIM:CLBX, FRA:DWV) is in advanced talks with one of the largest private US healthcare providers to deploy its Parsortix cancer diagnostic platform. In a first quarter trading update, the company guided for revenues of at least £2.1 million this year, a 50% increase, with further upgrades possible if pipeline deals convert.

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) has secured a Canadian patent for its POLB 001 drug candidate in preventing cancer immunotherapy-induced cytokine release syndrome. CEO Jeremy Skillington says the grant strengthens the drug's appeal to partners ahead of interim trial data expected this summer.

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) lifted EBITDA 50% to $33.87 million in the first quarter as a gold price of $4,816 per ounce more than offset lower production at its Blanket mine. Free cash flow more than doubled and the board has approved a quarterly dividend of 14 cents per share.

Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) has raised £8 million from existing institutional investors to accelerate development at its Pitfield Titanium Project in Western Australia. The company now has around £14.5 million in cash and says its planned ASX dual listing remains on track for the second half of 2026.

88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has secured its 20% stake in Namibia's PEL 93 on an unconditional basis while cutting around $15 million of future funding obligations. The company retains exposure to a potentially basin-opening play while keeping its focus on its priority Alaskan assets.

Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) has consented to Elevra Lithium transferring its 22.5% interest in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt. The move is expected to simplify funding and accelerate development of what could be Ghana's first lithium mine.

Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

View Comments